Article Details

Zacks: Analysts Expect REGENXBIO Inc. (NASDAQ:RGNX) Will Post Quarterly Sales of $27.97 ...

Retrieved on: 2021-04-10 05:15:00

Tags for this article:

Click the tags to see associated articles and topics

Zacks: Analysts Expect REGENXBIO Inc. (NASDAQ:RGNX) Will Post Quarterly Sales of $27.97 .... View article details on hiswai:

Excerpt

AQR Capital Management LLC now owns 14,794 shares of the biotechnology company's stock worth $407,000 after purchasing an additional 5,313 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up